Tanya Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-01-2025
- Paid Up Capital ₹ 0.10 M
as on 11-01-2025
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 55.00 Cr
as on 11-01-2025
- Revenue -12.00%
(FY 2020)
- Profit -68.60%
(FY 2020)
- Ebitda -68.60%
(FY 2020)
- Net Worth -7.57%
(FY 2020)
- Total Assets 0.45%
(FY 2020)
About Tanya Pharma
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹55.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Harsh Gupta and Sandeep Handa serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PTC059153
- Company No.
059153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 1994
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tanya Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harsh Gupta  | Director | 15-Feb-2019 | Current |
| Sandeep Handa | Director | 03-Aug-2007 | Current |
Financial Performance of Tanya Pharma.
Tanya Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12% decrease. The company also saw a substantial fall in profitability, with a 68.6% decrease in profit. The company's net worth dipped by a decrease of 7.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tanya Pharma?
In 2020, Tanya Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arsa Trading And Finance Pvt. Ltd.Active 30 years 16 daysHarsh Gupta and Sandeep Handa are mutual person
- Everlike Properties Private LimitedActive 35 years 8 days
Harsh Gupta and Sandeep Handa are mutual person
- Aman Developers Private LimitedActive 34 years 4 months
Harsh Gupta and Sandeep Handa are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Il&Fs Financial Services Limited Creation Date: 18 Mar 2009 | ₹55.00 Cr | Satisfied |
How Many Employees Work at Tanya Pharma?
Unlock and access historical data on people associated with Tanya Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tanya Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tanya Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
